Sciatica
sciatica lumbar radiculopathy treatment
| Root | Level | Pain/Sensory Loss | Motor Weakness | Reflex |
|---|---|---|---|---|
| L4 | L3-L4 disc | Anterior thigh/medial leg | Knee extension | Knee jerk |
| L5 | L4-L5 disc | Anterior leg, dorsal foot, great toe | Foot dorsiflexion, EHL, eversion | None (or tibialis posterior) |
| S1 | L5-S1 disc | Plantar/lateral foot | Plantar flexion, peroneals | Ankle jerk |

Typhoid..at last pathophysiology in flowchart form
INGESTION OF S. Typhi / S. Paratyphi
(contaminated food or water, fecal-oral route)
│
▼
GASTRIC ACID BARRIER
├─ Normal acid → most organisms killed
└─ Achlorhydria / large inoculum → organisms survive
│
▼
SMALL INTESTINE (Terminal Ileum)
S. Typhi penetrates intestinal epithelium via M cells
overlying Peyer's patches
│
▼
UPTAKE BY MONONUCLEAR PHAGOCYTES
in the lamina propria (submucosal lymphoid tissue)
• Unlike NTS: NO massive neutrophil infiltration
• Mononuclear (macrophage) predominant response
• Key virulence factor: Vi antigen (capsule) resists
phagocytic killing → intracellular survival
│
▼
PEYER'S PATCHES ENLARGE
Plateaulike elevations up to 8 cm in terminal ileum
│
├──────────────────────────────────────────┐
▼ ▼
PRIMARY BACTEREMIA LYMPHATIC SPREAD
(1st-2nd week) Organisms travel to mesenteric
• Organisms enter portal circulation lymph nodes → reactive
• Seeded into liver, spleen, hyperplasia
gallbladder, bone marrow Bacteria-laden phagocytes
• Blood cultures POSITIVE (90%) accumulate
│
▼
MULTIPLICATION INSIDE MACROPHAGES
(in liver, spleen, bone marrow, lymph nodes)
• "Typhoid nodules" - small foci of parenchymal
necrosis with macrophage aggregates in liver,
bone marrow, lymph nodes
• Spleen: red pulp expansion from phagocyte hyperplasia
• Relative bradycardia (endotoxin effect on myocardium)
│
▼
SECONDARY (SUSTAINED) BACTEREMIA
(end of Week 1 → Week 2–3)
• Massive re-seeding from intracellular reservoir
• Systemic cytokine release (IL-1, TNF, IL-6)
• Sustained high fever (38.8–40.5°C) for weeks
• Rose spots: small erythematous maculopapular
lesions on trunk/chest (S. Typhi in punch biopsy)
│
├────────────────────┬────────────────────┐
▼ ▼ ▼
GALLBLADDER INTESTINAL SYSTEMIC ORGANS
SEEDING CHANGES (Week 2–4)
• Organisms survive (Week 3–4)
in bile, gallstones Peyer's patch
• Chronic carrier state hyperplasia →
(2–5%) → re-excrete necrosis → ulceration
via bile into gut (oval ulcers along long
• ↑ Risk of axis of ileum)
gallbladder cancer │
┌─────┴──────┐
▼ ▼
PERFORATION HEMORRHAGE
(~1%) (~6%)
(life- (life-
threatening) threatening)
Peritonitis Bowel resection
│
▼
COMPLICATIONS (~27% of hospitalized)
• Neurologic: meningitis, Guillain-Barré,
encephalopathy ("muttering delirium",
"coma vigil"), neuritis
• Cardiac: myocarditis, endocarditis,
pericarditis
• Pulmonary: pneumonia
• Renal: glomerulonephritis, HUS
• Hematologic: DIC, hemophagocytic syndrome
• Hepatobiliary: hepatitis, splenic/hepatic
abscess, cholecystitis
• MSK: osteomyelitis, arthritis
| Week | Pathophysiology | Clinical Features |
|---|---|---|
| Week 1 | Primary bacteremia; seeding of RES | Stepwise rising fever, headache, malaise, relative bradycardia, dry cough |
| Week 2 | Sustained secondary bacteremia; cytokine storm | Continuous high fever (plateau), rose spots, splenomegaly, hepatomegaly, abdominal pain |
| Week 3 | Peyer's patch ulceration; peak systemic illness | Delirium ("muttering"), worsening abdominal symptoms; perforation/hemorrhage risk begins |
| Week 4 | Resolution OR complications | Fever resolves or complications emerge; 10% relapse within 2-3 weeks |
| Feature | Detail |
|---|---|
| Causative agent | Salmonella enterica serotype Typhi (mainly); Paratyphi A, B, C |
| Reservoir | Humans only - no animal reservoir for S. Typhi |
| Transmission | Fecal-oral via contaminated water/food; chronic carriers |
| Incubation | 5-21 days (mean 10-14 days) |
| Infective dose | Variable; lower with achlorhydria |
Typhoid